Alvotech (ALVO)

NASDAQ

$5.45

$+0.38

(+7.39%)

Pre-Market

Alvotech (ALVO) Live Price Chart

Last updated: ⁦2026-10-20 13:18:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Alvotech (ALVO) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $5.45, with a market capitalization of $1.78B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.94 to $8.75. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.78B
Open	$5.08
Day's High	$18.00
Day's Low	$2.94
Previous Close	$5.03
Volume	199.61K
Average Volume	1.11M
P/E Ratio	--
52-Week High	$8.74
52-Week Low	$2.94
Dividend Yield	--
Earnings Date	--

Alvotech (ALVO) Pre-Market Stock Price

Alvotech (ALVO) is trading at $5.45 in pre-market trading as of 2026-10-20 13:17:00, up 8.35% ($0.42) from the previous close of $5.03

Pre-market trading shows how investors are pricing ALVO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Alvotech (ALVO) 7-Day Stock Price Change

Over the past seven days, Alvotech (ALVO) moved from $5.78 to $5.45, representing a decline of 5.71% ($0.33).

The stock traded between $4.95 and $5.89 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 991.92 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ALVO 52-Week Price Position

Position in Range: 43.2%

52W Low$2.94

52W High$8.75

ALVO is currently trading at $5.45, placing it 43.2% of the way from its 52-week low of $2.94 to its 52-week high of $8.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Alvotech (ALVO)?

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Alvotech Information

Employees	1460
Exchange	NASDAQ
Company Website	https://www.alvotech.com

How to Buy Alvotech (ALVO) Stock on MEXC

Eligible investors can buy real shares of Alvotech (ALVO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ALVO and Place Your Order

Open the RealStocks trading page and search for ALVO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Alvotech (ALVO) stock price today?

Alvotech (ALVO) is currently trading at $ 5.45, up 8.35% ($0.42) from the previous close of $ 5.03. Intraday prices update in real time during regular trading hours.

2.Is ALVO stock going up or down today?

As of 2026-10-20 13:17:00, ALVO is trading at $ 5.45, up 8.35% ($0.42) from its previous close of $ 5.03. The stock has traded between $ 2.94 and $ 18.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is ALVO pre-market price?

As of 2026-10-20 13:17:00, ALVO is trading at $ 5.45 in pre-market trading, up 8.35% ($0.42) from the previous close of $ 5.03. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ALVO after-hours price?

As of 2026-10-20 13:17:00, ALVO is trading at $ 5.08 in after-hours trading, up 0.89% ($0.04) from the regular-session close of $ 5.03. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ALVO stock trading now?

ALVO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ALVO sit relative to its 52-week high and low?

Over the past 52 weeks, ALVO has traded between a low of $ 2.94 and a high of $ 8.75. At $ 5.45, the stock is positioned 43.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Alvotech in?

Alvotech (ALVO) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Alvotech's market capitalization and where is it listed?

Alvotech is listed on the NASDAQ exchange with a market capitalization of $ 1.78B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ALVO valued in terms of P/E ratio and EPS?

ALVO trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Alvotech pay a dividend?

Alvotech pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.